Rare diseases
Investigational molecules
Locations
Back to Portugal638 clinical trials in Lisbon, Portugal across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
PortugalStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
PortugalStudy on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
PortugalSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
PortugalPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
PortugalStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
PortugalEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
PortugalStudy of subcutaneous anifrolumab pharmacokinetics, pharmacodynamics and safety in children aged 5 to <18 years with systemic lupus erythematosus
PortugalStudy of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy
PortugalRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
PortugalA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
PortugalEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancer treatments and advanced lung cancer therapies, combining novel approaches with standard treatments.
Studies evaluate targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into various autoimmune disorders, with particular focus on psoriasis and systemic sclerosis treatments.
Testing innovative biological therapies and novel treatment approaches.
Studies examining treatments for Dravet Syndrome and Alzheimer's-related psychosis, focusing on improving patient quality of life.
Investigating new therapeutic options for challenging neurological conditions.
Research targeting Crohn's Disease and various inflammatory conditions, evaluating new treatment combinations.
Testing advanced therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
